Description
An anti-migraine agent; binds to connexin43 hemichannels and inhibits ATP release in vitro during injury and reperfusion in a dose-dependent manner; blocks trigeminal ganglion neuronal-satellite glial cell signaling and cortical spreading depression; in vivo (10 mg/kg) increases the seizure threshold in MEST mice and rats (143 and 1192%, respectively); blocks neurogenic plasma extravasation in a rat trigeminal nerve migraine model,
Formal name: N-[(3S,4S)-6-acetyl-3,4-dihydro-3-hydroxy-2,2-dimethyl-2H-1-benzopyran-4-yl]-3-chloro-4-fluoro-benzamide
Synonyms: SB-220453
Molecular weight: 391.8
CAS: 175013-84-0
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Neuroscience|Pain Research